Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease.

Prostaglandins may be important regulators of coronary blood flow. To investigate this possibility, we studied the effect of blockade of prostaglandin synthesis by indomethacin in nine patients with coronary-artery disease. Coronary-sinus blood flow (determined with the thermodilution technique) was recorded, together with mean arterial blood pressure and the myocardial arteriovenous oxygen difference from simultaneously obtained arterial and coronary-sinus blood samples, before and 20 minutes after an intravenous dose of indomethacin (0.5 mg per kilogram of body weight). There were significant increases (P less than 0.05) in mean arterial pressure (from 99 +/- 4 to 118 +/- 5 mm Hg [+/- S.E.M.]), coronary vascular resistance (+73 per cent), and myocardial arteriovenous oxygen difference (from 107 +/- 5 to 138 +/- 4 ml per liter) after indomethacin, but coronary blood flow fell significantly, from 181 +/- 29 to 111 +/- 14 ml per minute (P less than 0.05). Thus, despite an increase in myocardial oxygen demand, coronary blood flow fell and coronary vascular resistance increased. This coronary vasoconstrictor effect may have been due to blockade of vasodilatory prostaglandin synthesis or to a direct drug effect. Whatever the mechanism, indomethacin should be used with caution in patients with severe coronary-artery disease.

[1]  L. Hillis,et al.  Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.

[2]  R. Eisinger,et al.  Indomethacin-associated acute renal failure. , 1980, The American journal of medicine.

[3]  G. Mudge,et al.  Comparison of Metabolic and Vasoconstrictor Stimuli on Coronary Vascular Resistance in Man , 1979, Circulation.

[4]  P. Needleman,et al.  Cardiac and coronary prostaglandin synthesis and function. , 1978, The New England journal of medicine.

[5]  B. Zaret,et al.  Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery disease. , 1977, The American journal of cardiology.

[6]  R. M. Mills,et al.  Reflex increase in coronary vascular resistance in patients with ischemic heart disease. , 1976, The New England journal of medicine.

[7]  J. Folts,et al.  Prostaglandin-like substances in coronary venous blood following myocardial ischemia. , 1976, The Journal of pharmacology and experimental therapeutics.

[8]  R. Alexander,et al.  Stimulation of prostaglandin E synthesis in cultured human umbilical vein smooth muscle cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Arisz,et al.  The effect of indomethacin on kidney function and plasma renin activity in man. , 1976, Nephron.

[10]  P. Cannon,et al.  The relationship between regional myocardial perfusion at rest and arteriographic lesions in patients with coronary atherosclerosis. , 1975, The Journal of clinical investigation.

[11]  G. Marshall,et al.  Hormone Interactions in the Isolated Rabbit Heart: SYNTHESIS AND CORONARY VASOMOTOR EFFECTS OF PROSTAGLANDINS, ANGIOTENSIN, AND BRADYKININ , 1975, Circulation research.

[12]  L. Bertilsson,et al.  Pharmacokinetics of indomethacin , 1975, Clinical pharmacology and therapeutics.

[13]  R. Alexander,et al.  Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. , 1975, Science.

[14]  K. Kent,et al.  Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. , 1975, The Journal of clinical investigation.

[15]  J. Vane,et al.  Anoxia‐Induced Release of Prostaglandins in Rabbit Isolated Hearts , 1975, Circulation research.

[16]  J. Mcgiff,et al.  Dependency of Renal Blood Flow on Prostaglandin Synthesis in the Dog , 1973, Circulation research.

[17]  M. Hamberg,et al.  Inhibition of prostaglandin synthesis in man. , 1972, Biochemical and biophysical research communications.

[18]  F. Mcmahon,et al.  The metabolism of indomethacin in man. , 1972, The Journal of pharmacology and experimental therapeutics.

[19]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.

[20]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[21]  G G Rowe,et al.  A Study of Hemodynamics and Coronary Blood Flow in Man with Coronary Artery Disease , 1969, Circulation.

[22]  R. Berne,et al.  Regulation of coronary blood flow. , 1975, Progress in cardiovascular diseases.